Living-donor lobar lung transplantation for infectious lung diseases

Hiroshi Date, Masaomi Yamane, S. Toyooka, M. Okazaki, Takahiro Oto, Y. Sano, K. Goto

Research output: Contribution to journalArticlepeer-review


The rate of infection among lung transplant recipients is several times higher than that among recipients of other organs and is most likely related to the exposure of the allograft to the external environment. Meticulous peri-operative management is mandatory in performing living-donor lobar lung transplantation for patients with infectious lung diseases. All 5 patients with end-stage infectious lung diseases are currently alive for 17-104 months after receiving living-donor lobar lung transplantation at Okayama University Hospital.

Original languageEnglish
Pages (from-to)1005-1009
Number of pages5
JournalKyobu geka. The Japanese journal of thoracic surgery
Issue number11
Publication statusPublished - Oct 2007

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Living-donor lobar lung transplantation for infectious lung diseases'. Together they form a unique fingerprint.

Cite this